These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 37146461)

  • 1. Polygenic overlap with body-mass index improves prediction of treatment-resistant schizophrenia.
    O'Connell KS; Koch E; Lenk HÇ; Akkouh IA; Hindley G; Jaholkowski P; Smith RL; Holen B; Shadrin AA; Frei O; Smeland OB; Steen NE; Dale AM; Molden E; Djurovic S; Andreassen OA
    Psychiatry Res; 2023 Jul; 325():115217. PubMed ID: 37146461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polygenic Risk Score for Schizophrenia and Treatment-Resistant Schizophrenia.
    Wimberley T; Gasse C; Meier SM; Agerbo E; MacCabe JH; Horsdal HT
    Schizophr Bull; 2017 Sep; 43(5):1064-1069. PubMed ID: 28184875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia.
    Pardiñas AF; Smart SE; Willcocks IR; Holmans PA; Dennison CA; Lynham AJ; Legge SE; Baune BT; Bigdeli TB; Cairns MJ; Corvin A; Fanous AH; Frank J; Kelly B; McQuillin A; Melle I; Mortensen PB; Mowry BJ; Pato CN; Periyasamy S; Rietschel M; Rujescu D; Simonsen C; St Clair D; Tooney P; Wu JQ; Andreassen OA; Kowalec K; Sullivan PF; Murray RM; Owen MJ; MacCabe JH; O'Donovan MC; Walters JTR; ; Ajnakina O; Alameda L; Barnes TRE; Berardi D; Bonora E; Camporesi S; Cleusix M; Conus P; Crespo-Facorro B; D'Andrea G; Demjaha A; Do KQ; Doody GA; Eap CB; Ferchiou A; Di Forti M; Guidi L; Homman L; Jenni R; Joyce EM; Kassoumeri L; Khadimallah I; Lastrina O; Muratori R; Noyan H; O'Neill FA; Pignon B; Restellini R; Richard JR; Schürhoff F; Španiel F; Szöke A; Tarricone I; Tortelli A; Üçok A; Vázquez-Bourgon J
    JAMA Psychiatry; 2022 Mar; 79(3):260-269. PubMed ID: 35019943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polygenic overlap between schizophrenia risk and antipsychotic response: a genomic medicine approach.
    Ruderfer DM; Charney AW; Readhead B; Kidd BA; Kähler AK; Kenny PJ; Keiser MJ; Moran JL; Hultman CM; Scott SA; Sullivan PF; Purcell SM; Dudley JT; Sklar P
    Lancet Psychiatry; 2016 Apr; 3(4):350-7. PubMed ID: 26915512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deconstructing the genetic architecture of treatment-resistant schizophrenia in East Asian ancestry.
    Lim K; Yee JY; See YM; Ng BT; Zheng S; Tang C; Lencz T; Lee J; Lam M
    Asian J Psychiatr; 2023 Dec; 90():103826. PubMed ID: 37944474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression imputation provides clinical and biological insights into treatment-resistant schizophrenia polygenic risk.
    Prohens L; Rodríguez N; Segura ÀG; Martínez-Pinteño A; Olivares-Berjaga D; Martínez I; González A; Mezquida G; Parellada M; Cuesta MJ; Bernardo M; Gassó P; Mas S
    Psychiatry Res; 2024 Feb; 332():115722. PubMed ID: 38198858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polygenic risk scores for schizophrenia and treatment resistance: New data, systematic review and meta-analysis.
    Facal F; Costas J
    Schizophr Res; 2023 Feb; 252():189-197. PubMed ID: 36657363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systems-Level Analysis of Genetic Variants Reveals Functional and Spatiotemporal Context in Treatment-resistant Schizophrenia.
    Talarico F; Costa GO; Ota VK; Santoro ML; Noto C; Gadelha A; Bressan R; Azevedo H; Belangero SI
    Mol Neurobiol; 2022 May; 59(5):3170-3182. PubMed ID: 35278208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disorganization domain as a putative predictor of Treatment Resistant Schizophrenia (TRS) diagnosis: A machine learning approach.
    Barone A; De Prisco M; Altavilla B; Avagliano C; Balletta R; Buonaguro EF; Ciccarelli M; D'Ambrosio L; Giordano S; Latte G; Matrone M; Milandri F; Francesco DN; Vellucci L; de Bartolomeis A
    J Psychiatr Res; 2022 Nov; 155():572-578. PubMed ID: 36206601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Treatment-Resistant and Clozapine-Resistant Schizophrenia: A 12-Year Follow-up Study of First-Episode Schizophrenia-Spectrum Disorders.
    Chan SKW; Chan HYV; Honer WG; Bastiampillai T; Suen YN; Yeung WS; Lam M; Lee WK; Ng RMK; Hui CLM; Chang WC; Lee EHM; Chen EYH
    Schizophr Bull; 2021 Mar; 47(2):485-494. PubMed ID: 33043960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on novel antipsychotics and pharmacological strategies for treatment-resistant schizophrenia.
    de Bartolomeis A; Ciccarelli M; Vellucci L; Fornaro M; Iasevoli F; Barone A
    Expert Opin Pharmacother; 2022 Dec; 23(18):2035-2052. PubMed ID: 36368055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of clinical parameters and polygenic risk scores for body mass index, schizophrenia, and diabetes with antipsychotic-induced weight gain.
    Franz M; Papiol S; Simon MS; Barton BB; Glockner C; Spellmann I; Riedel M; Heilbronner U; Zill P; Schulze TG; Musil R
    J Psychiatr Res; 2024 Jan; 169():184-190. PubMed ID: 38042056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity and efficacy of antipsychotic treatment for schizophrenia with or without treatment resistance: a meta-analysis.
    Mizuno Y; McCutcheon RA; Brugger SP; Howes OD
    Neuropsychopharmacology; 2020 Mar; 45(4):622-631. PubMed ID: 31766049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: A retrospective 6-month mirror-image study.
    Bioque M; Parellada E; García-Rizo C; Amoretti S; Fortea A; Oriolo G; Palau P; Boix-Quintana E; Safont G; Bernardo M
    Eur Psychiatry; 2020 Jul; 63(1):e71. PubMed ID: 32669145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial.
    Zhu MH; Liu ZJ; Hu QY; Yang JY; Jin Y; Zhu N; Huang Y; Shi DH; Liu MJ; Tan HY; Zhao L; Lv QY; Yi ZH; Wu FC; Li ZZ
    Mil Med Res; 2022 Oct; 9(1):59. PubMed ID: 36253804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated intrinsic cortical curvature in treatment-resistant schizophrenia: Evidence of structural deformation in functional connectivity areas and comparison with alternate indices of structure.
    Torres-Carmona E; Ueno F; Iwata Y; Nakajima S; Song J; Mar W; Abdolizadeh A; Agarwal SM; de Luca V; Remington G; Gerretsen P; Graff-Guerrero A
    Schizophr Res; 2024 Jul; 269():103-113. PubMed ID: 38761434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between the examination rate of treatment-resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study.
    Yasui-Furukori N; Muraoka H; Hasegawa N; Ochi S; Numata S; Hori H; Hishimoto A; Onitsuka T; Ohi K; Hashimoto N; Nagasawa T; Takaesu Y; Inagaki T; Tagata H; Tsuboi T; Kubota C; Furihata R; Iga JI; Iida H; Miura K; Matsumoto J; Yamada H; Watanabe K; Inada K; Shimoda K; Hashimoto R
    Neuropsychopharmacol Rep; 2022 Mar; 42(1):3-9. PubMed ID: 34854260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment-Resistant Schizophrenia, Clozapine Resistance, Genetic Associations, and Implications for Precision Psychiatry: A Scoping Review.
    Ying J; Chew QH; McIntyre RS; Sim K
    Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genetic locus in 7p12.2 associated with treatment resistant schizophrenia.
    Li J; Meltzer HY
    Schizophr Res; 2014 Nov; 159(2-3):333-9. PubMed ID: 25223841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered Patterns of Brain Glucose Metabolism Involve More Extensive and Discrete Cortical Areas in Treatment-resistant Schizophrenia Patients Compared to Responder Patients and Controls: Results From a Head-to-Head 2-[18F]-FDG-PET Study.
    Iasevoli F; D'Ambrosio L; Ciccarelli M; Barone A; Gaudieri V; Cocozza S; Pontillo G; Brunetti A; Cuocolo A; de Bartolomeis A; Pappatà S
    Schizophr Bull; 2023 Mar; 49(2):474-485. PubMed ID: 36268829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.